Emerging roles of autophagy in the development and treatment of urothelial carcinoma of the bladder

References

• Tripathi K. Mutational analysis of ras hotspots in patients with urothelial carcinoma of the bladder. World J Clin Oncol. 2020;11(8):614–628.
   PubMed Web of Science ®Google Scholar
• Saginala K. Epidemiology of bladder cancer. Med Sci (Basel). 2020;8(1):15.
   PubMedGoogle Scholar
• Garg M. Recent advancements towards molecular insights and therapeutic targets in bladder cancer. In: Ja Hyeon K, editor. Bladder Cancer: research Advances and Clinical Challenges. Germany: Nova Science Publishers Inc; 2018. p. 1–31.
   Google Scholar
• Garg M, Maurya N. WNT/β-catenin signaling in urothelial carcinoma of bladder. World J Nephrol. 2019;8(5):83–94.
   PubMedGoogle Scholar
• Inamura K. Bladder cancer: new insights into its molecular pathology. Cancers (Basel). 2018;10(4):100.
   PubMed Web of Science ®Google Scholar
• Santoni M. Role of STAT3 pathway in genitourinary tumors. Future Sci OA. 2015;1(3):FSO15.
   PubMed Web of Science ®Google Scholar
• Garg M. Prognostic and therapeutic applications of the molecular events in clinical management of urothelial carcinoma of bladder. J Exp Ther Oncol. 2014;10(4):301–316.
   PubMedGoogle Scholar
• Garg M. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer Metast Rev. 2015;34(4):691–701.
   PubMed Web of Science ®Google Scholar
• Leppert JT. Prevention of bladder cancer: a review. Eur Urol. 2006;49:226–234.
   PubMed Web of Science ®Google Scholar
• Lattouf JB. Chemoprevention in bladder cancer: what’s new? Can Urol Assoc J. 2009;3:S184–S187.
   PubMed Web of Science ®Google Scholar
• Tanaka T. Pathobiology and chemoprevention of bladder cancer. J Oncol. 2011;2011:528353.
   PubMedGoogle Scholar
• Stein JP. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675.
   PubMed Web of Science ®Google Scholar
• Yafi FA. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int. 2011;108:539–545.
   PubMed Web of Science ®Google Scholar
• Grossman HB. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–866.
   PubMed Web of Science ®Google Scholar
• Chandrasekar T, Evans CP. Autophagy and urothelial carcinoma of the bladder: a review. Investig Clin Urol. 2016;57(Suppl 1):S89–S97.
   PubMedGoogle Scholar
• Abufaraj M. Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery. Transl Androl Urol. 2016;5:735–744.
   PubMed Web of Science ®Google Scholar
• Konac E, Kurman Y, Baltaci S, et al. Contrast effects of autophagy in the treatment of bladder cancer. Exp Biol Med (Maywood). 2021;246(3):354–367.
   PubMed Web of Science ®Google Scholar
• Alhalabi O. Current and future landscape of immune checkpoint inhibitors in urothelial cancer. Oncology (Williston Park). 2019;33(1):11–18.
   PubMed Web of Science ®Google Scholar
• Vlachostergios PJ. Antibody-drug conjugates in bladder cancer. Bladder Cancer. 2018;4(3):247–259.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Marino G, Levine B, et al. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280–293.
   PubMed Web of Science ®Google Scholar
• Zhang J. Statins, autophagy and cancer metastasis. Int J Biochem Cell Biol. 2013;45:745–752.
   PubMed Web of Science ®Google Scholar
• Mizushima N. Autophagy: process and function. Genes Dev. 2007;21(22):2861–2873.
   PubMed Web of Science ®Google Scholar
• Cheng Y. Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev. 2013;65:1162–1197.
   PubMed Web of Science ®Google Scholar
• Bishop E, Bradshaw TD. Autophagy modulation: a prudent approach in cancer treatment? Cancer Chemother Pharmacol. 2018;82(6):913–922.
   PubMed Web of Science ®Google Scholar
• Li YJ. Autophagy and multidrug resistance in cancer. Chin J Cancer. 2017;36:52.
   PubMedGoogle Scholar
• Garg M. Epithelial plasticity, autophagy and metastasis: potential modifiers of the crosstalk to overcome therapeutic resistance. Stem Cell Rev Rep. 2020;16(3):503–510.
   PubMed Web of Science ®Google Scholar
• Li F. Autophagy modulation in bladder cancer development and treatment (review). Oncol Rep. 2019;42:1647–1655.
   PubMed Web of Science ®Google Scholar
• Mukherjee A. Selective endosomal microautophagy is starvation-inducible in drosophila. Autophagy. 2016;12:1984–1999.
   PubMed Web of Science ®Google Scholar
• Marinković M. Autophagy modulation in cancer: current knowledge on action and therapy. Oxid Med Cell Longev. 2018;2018:8023821.
   PubMed Web of Science ®Google Scholar
• Vicencio JM. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ. 2009;16(7):1006–1017.
   PubMed Web of Science ®Google Scholar
• Kang S. Autophagy-related (ATG) 11, ATG9 and the phosphatidylinositol 3-kinase control ATG2-mediated formation of autophagosomes in arabidopsis. Plant Cell Rep. 2018;37(4):653–664.
   PubMed Web of Science ®Google Scholar
• Döring T. Hepatitis B virus subverts the autophagy elongation complex Atg5-12/16L1 and does not require Atg8/LC3 lipidation for viral maturation. J Virol. 2018;92(7):e01513–e01517.
   PubMed Web of Science ®Google Scholar
• Kwon DH. Insights into degradation mechanism of N-end rule substrates by p62/SQSTM1 autophagy adapter. Nat Commun. 2018;9:3291.
   PubMed Web of Science ®Google Scholar
• Pattingre S. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122:927–939.
   PubMed Web of Science ®Google Scholar
• Grunwald DS. GABARAPs and LC3s have opposite roles in regulating ULK1 for autophagy induction. Autophagy. 2020;16(4):600–614.
   PubMed Web of Science ®Google Scholar
• Ersahin T, Tuncbag N, Cetin-Atalay R, et al. The PI3K/AKT/mTOR interactive pathway. Mol Biosyst. 2015;11(7):1946–1954.
   PubMedGoogle Scholar
• Huang J, Bd M. The TSC1–TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008;412(2):179–190.
   PubMed Web of Science ®Google Scholar
• Luo S, Rubinsztein DC. Atg5 and Bcl-2provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ. 2007;14:1247–1250.
   PubMed Web of Science ®Google Scholar
• Schaaf MB. The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia. Radiother Oncol. 2013;108(3):529–534.
   PubMed Web of Science ®Google Scholar
• Feng Z. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA. 2005;102(23):8204–8209.
   PubMed Web of Science ®Google Scholar
• Crighton D. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 2006;126:121–134.
   PubMed Web of Science ®Google Scholar
• Ojha R. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent. J Urol. 2014;191(6):1889–1898.
   PubMed Web of Science ®Google Scholar
• Sivridis E. Patterns of autophagy in urothelial cell carcinomas: the significance of “stone-like” structures (SLS) in transurethral resection biopsies. Urol Oncol. 2013;31:1254–1260.
   PubMed Web of Science ®Google Scholar
• Lin YC. Inhibition of high basal level of autophagy induces apoptosis in human bladder cancer cells. J Urol. 2016;195(4 Pt 1):1126–1135.
   PubMed Web of Science ®Google Scholar
• Baspinar S. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters. Pathol Res Pract. 2013;209:418–423.
   PubMed Web of Science ®Google Scholar
• Shen B. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy. Tumour Biol. 2016;37:7371–7381.
   PubMed Web of Science ®Google Scholar
• Sharif T. Autophagic homeostasis is required for the pluripotency of cancer stem cells. Autophagy. 2017;13:264–284.
   PubMed Web of Science ®Google Scholar
• Schlütermann D. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. Urol Oncol. 2018;36:160. e1-160.e13.
   PubMed Web of Science ®Google Scholar
• Wang F. Chloroquine enhances the radiosensitivity of bladder cancer cells by inhibiting autophagy and activating apoptosis. Cell Physiol Biochem. 2018;45(1):54–66.
   PubMed Web of Science ®Google Scholar
• Yu X, Long YC, Shen HM, et al. Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy. Autophagy. 2015;11:1711–1728.
   PubMed Web of Science ®Google Scholar
• Fan B. Fangchinoline induces apoptosis, autophagy and energetic impairment in bladder cancer. Cell Physiol Biochem. 2017;43:1003–1011.
   PubMed Web of Science ®Google Scholar
• Pan XW. Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy. Oncol Rep. 2016;35:334–342.
   PubMed Web of Science ®Google Scholar
• Dyshlovoy SA. The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells. BMC Cancer. 2017;17:93.
   PubMed Web of Science ®Google Scholar
• Vinod V. ‘How can I halt thee?’ the puzzles involved in autophagic inhibition. Pharmacol Res. 2014;82:1–8.
   PubMed Web of Science ®Google Scholar
• Kang M. Concurrent autophagy inhibition overcomes the resistance of epidermal growth factor receptor tyrosine kinase inhibitors in human bladder cancer cells. Int J Mol Sci. 2017;18(2):321.
   Web of Science ®Google Scholar
• Lin JF. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells. Drug Des Devel Ther. 2017;11:1517–1533.
   PubMed Web of Science ®Google Scholar
• Ojha R, Jha V, Singh SK, et al. Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells. Biochim Biophys Acta. 2016;1863(2):347–359.
   PubMed Web of Science ®Google Scholar
• Buffen K. Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog. 2014;10:e1004485.
   PubMed Web of Science ®Google Scholar
• Benedict WF. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein. Mol Ther. 2004;10:525–532.
   PubMed Web of Science ®Google Scholar
• Zhang XQ, Dunner K Jr, Benedict WF, et al. Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced. Cancer Gene Ther. 2010;17:579–584.
   PubMed Web of Science ®Google Scholar
• Li K. Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells. Biochem Biophys Res Commun. 2015;460(2):380–385.
   PubMed Web of Science ®Google Scholar
• Arum CJ. Tissue responses to hexyl 5-aminolevulinateinduced photodynamic treatment in syngeneic orthotopic rat bladder cancer model: possible pathways of action. J Biomed Opt. 2011;16:028001.
   PubMed Web of Science ®Google Scholar
• Chou R. Treatment of muscle-invasive bladder cancer: a systematic review. Cancer. 2016;122:842–851.
   PubMed Web of Science ®Google Scholar
• Shrivastava S. The role of HMGB1 in radioresistance of bladder cancer. Mol Cancer Ther. 2016;15(3):471–479.
   PubMed Web of Science ®Google Scholar
• Chiao MT. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. Autophagy. 2013;9:1509–1526.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer Res. 2014;74(3):647–651.
   PubMed Web of Science ®Google Scholar
• Santoni M. Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells. Br J Cancer. 2013;109:1040–1050.
   PubMed Web of Science ®Google Scholar
• Hua X. New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating Sestrin-2 in human bladder cancer. Cancer Lett. 2018;436:38–51.
   PubMed Web of Science ®Google Scholar
• Wang X. Ubenimex, an APN inhibitor, could serve as an anti-tumor drug in RT112 and 5637 cells by operating in an Akt-associated manner. Mol Med Rep. 2018;17:4531–4539.
   PubMed Web of Science ®Google Scholar
• Li T, Xu K, Liu Y, et al. Anticancer effect of salidroside reduces viability through autophagy/PI3K/Akt and MMP-9 signaling pathways in human bladder cancer cells. Oncol Lett. 2018;16:3162–3168.
   PubMed Web of Science ®Google Scholar
• Kou B. Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells. Oncol Rep. 2017;38(5):3137–3143.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A, et al. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9): 528–542.
   PubMed Web of Science ®Google Scholar
• Huang KH. Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells. PLoS ONE. 2013;8:e82034.
   PubMed Web of Science ®Google Scholar